Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Debt to Equity (2020 - 2021)

Tenax Therapeutics' Debt to Equity history spans 3 years, with the latest figure at -$1.68 for Q2 2013.

  • On a quarterly basis, Debt to Equity rose 57.18% to -$1.68 in Q2 2013 year-over-year; TTM through Apr 2013 was -$1.68, a 57.18% increase, with the full-year FY2013 number at -$1.68, up 57.18% from a year prior.
  • Debt to Equity hit -$1.68 in Q2 2013 for Tenax Therapeutics, down from -$1.62 in the prior quarter.
  • Over the last five years, Debt to Equity for TENX hit a ceiling of -$1.09 in Q1 2012 and a floor of -$37.53 in Q4 2012.
  • Historically, Debt to Equity has averaged -$6.1 across 3 years, with a median of -$1.68 in 2013.
  • Biggest five-year swings in Debt to Equity: tumbled 2163.01% in 2012 and later skyrocketed 57.18% in 2013.
  • Tracing TENX's Debt to Equity over 3 years: stood at -$1.66 in 2011, then tumbled by 2163.01% to -$37.53 in 2012, then skyrocketed by 95.51% to -$1.68 in 2013.
  • Business Quant data shows Debt to Equity for TENX at -$1.68 in Q2 2013, -$1.62 in Q1 2013, and -$37.53 in Q4 2012.